Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke B Hesson

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Clinical Epigenetics|January 2, 2015
The importance of distinguishing pseudogenes from parental genesLuke B Hesson, Robyn L Ward
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2014
Discrimination of pseudogene and parental gene DNA methylation using allelic bisulfite sequencingLuke B Hesson, Robyn L Ward
Expert Review of Neurotherapeutics|October 22, 2008
Epigenetic markers in human gliomas: prospects for therapeutic interventionLuke B Hesson, Dietmar Krex, Farida Latif
Epigenetics|April 11, 2014
The evidence for functional non-CpG methylation in mammalian cellsVibha Patil, Robyn L Ward, Luke B Hesson
Disease Markers|February 28, 2007
The role of RASSF1A methylation in cancerLuke B Hesson, Wendy N Cooper, Farida Latif
Epigenomics|September 25, 2013
Establishing the clinical utility of epigenetic markers in cancer: many challenges aheadPeter Zarzour, Luke B Hesson, Robyn L Ward
Environmental Epigenetics|March 11, 2020
Non-CpG methylation biases bisulphite PCR towards low or unmethylated mitochondrial DNA: recommendations for the fieldMargaret J Morris, Luke B Hesson, Neil A Youngson
Clinical Epigenetics|April 21, 2016
Defining the criteria for identifying constitutional epimutationsMathew A Sloane, Robyn L Ward, Luke B Hesson
Current Opinion in Genetics & Development|April 3, 2010
Epimutations and cancer predisposition: importance and mechanismsLuke B Hesson, Megan P Hitchins, Robyn L Ward
Gene|March 27, 2016
An investigation of the potential for epigenetic inactivation by transcription read-through in a sporadic colorectal cancerSameer Srivastava, Anne K Ludwig, Jason W H Wong, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Clinical Epigenetics|January 2, 2015
The importance of distinguishing pseudogenes from parental genesLuke B Hesson, Robyn L Ward
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2014
Discrimination of pseudogene and parental gene DNA methylation using allelic bisulfite sequencingLuke B Hesson, Robyn L Ward
Expert Review of Neurotherapeutics|October 22, 2008
Epigenetic markers in human gliomas: prospects for therapeutic interventionLuke B Hesson, Dietmar Krex, Farida Latif
Epigenetics|April 11, 2014
The evidence for functional non-CpG methylation in mammalian cellsVibha Patil, Robyn L Ward, Luke B Hesson
Disease Markers|February 28, 2007
The role of RASSF1A methylation in cancerLuke B Hesson, Wendy N Cooper, Farida Latif
Epigenomics|September 25, 2013
Establishing the clinical utility of epigenetic markers in cancer: many challenges aheadPeter Zarzour, Luke B Hesson, Robyn L Ward
Environmental Epigenetics|March 11, 2020
Non-CpG methylation biases bisulphite PCR towards low or unmethylated mitochondrial DNA: recommendations for the fieldMargaret J Morris, Luke B Hesson, Neil A Youngson
Clinical Epigenetics|April 21, 2016
Defining the criteria for identifying constitutional epimutationsMathew A Sloane, Robyn L Ward, Luke B Hesson
Current Opinion in Genetics & Development|April 3, 2010
Epimutations and cancer predisposition: importance and mechanismsLuke B Hesson, Megan P Hitchins, Robyn L Ward
Gene|March 27, 2016
An investigation of the potential for epigenetic inactivation by transcription read-through in a sporadic colorectal cancerSameer Srivastava, Anne K Ludwig, Jason W H Wong, et al.
Pageof 5